Form D · Other
Gentem Health Inc
San Francisco, CA · CIK 0001799989
Offering snapshot reported Jan 14, 2020 · SEC filing
- Reported sold
- $3.79M Offering amount: $3.79M
- Investors reported
- 34 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Nov 15, 2019 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jan 14, 2020 | Initial | $3,789,481 | No comparison | 34 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-358003
Source: Form D, filed Jan 14, 2020. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Emmanuel Akintayo | Director, Executive |
| Olufisayo Ositelu | Director, Executive |
Issuer details
Industry: Other (See others in industry)
Address:
149 New Montgomery Street, 4th Floor
San Francisco, CA, 94105
San Francisco, CA, 94105